Expression of tissue-type transglutaminase (tTG) and the effect of tTG inhibitor on the hippocampal CA1 region after transient ischemia in gerbils

Brain Research

Volumn 1263, Issue , 2009, Pages 134-142

  Hwang, In Koo ^a   Yoo, Ki Yeon ^b   Yi, Sun Shin ^a   Kim, Il Yong ^a   Hwang, Hye Sook ^a   Lee, Kyung Yul ^c   Choi, Sun Mi ^d   Lee, In Se ^a   Yoon, Yeo Sung ^a   Kim, Soo Youl ^e   Won, Moo Ho ^b,f   Seong, Je Kyung ^a,g  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^e Division of Basic Sciences   (South Korea)

^f Hallym University   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Blood vessel; Cystamine; Iba 1; Ischemia; Microglia; PECAM 1; Transglutaminase 2

Indexed keywords

CD31 ANTIGEN; CYSTAMINE; INTEGRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN REGION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; LOCOMOTION; MALE; MICROGLIA; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; TRANSIENT ISCHEMIC ATTACK; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CYSTAMINE; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; GERBILLINAE; GTP-BINDING PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OXAZINES; REPERFUSION INJURY; TRANSGLUTAMINASES;

GERBILLINAE;

EID: 62249162878     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.038     Document Type: Article

References (52)

1. Akiyama H., Kondo H., Ikeda K., Arai T., Kato M., and McGleer P.L. Immunohistochemical detection of coagulation factor XIIIa in postmortem human brain tissue. Neurosci. Lett. 202 (1995) 29-32
2. Bian Q., Shi T., Chuang D.M., and Qian Y. Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils. Brain Res. 1184 (2007) 270-276
3. Büki A., Okonkwo D.O., Wang K.K., and Povlishock J.T. Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20 (2000) 2825-2834
4. Caccamo D., Campisi A., Currò M., Li Volti G., Vanella A., and Ientile R. Excitotoxic and post-ischemic neurodegeneration: involvement of transglutaminases. Amino Acids 27 (2004) 373-379
5. Casadio R., Polverini E., Mariani P., Spinozzi F., Carsughi F., Fontana A., Polverino de Laureto P., Matteucci G., and Bergamini C.M. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur. J. Biochem. 262 (1999) 672-679
6. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
7. Citron B.A., SantaCruz K.S., Davies P.J., and Festoff B.W. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J. Biol. Chem. 276 (2001) 3295-3301
8. Colbourne F., and Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J. Neurosci. 15 (1995) 7250-7260
9. n-expansion diseases?. Neurochem. Int. 40 (2002) 53-67
10. Dowden J., Reid C., Dooley P., and Corbett D. Diazepam-induced neuroprotection: dissociating the effects of hypothermia following global ischemia. Brain Res. 829 (1999) 1-6
11. Duncan G.S., Andrew D.P., Takimoto H., Kaufman S.A., Yoshida H., Spellberg J., Luis de la Pompa J., Elia A., Wakeham A., Karan-Tamir B., Muller W.A., Senaldi G., Zukowski M.M., and Mak T.W. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162 (1999) 3022-3030
12. Eitan S., Solomon A., Lavie V., Yoles E., Hirschberg D.L., Belkin M., and Schwartz M. Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science 264 (1994) 1764-1768
13. Fesus L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
14. Fesus L., Thomazy V., and Falus A. Reaching for function of tissue transglutaminase; its possible involvement in biochemical pathway of programmed cell death. Adv. Exp. Biol. 231 (1988) 119-139
15. Filiano A.J., Bailey C.D.C., Tucholski J., Gundemir S., and Johnson G.V.W. Transglutaminase 2 protects against ischemic insult, interacts with HIF1β, and attenuates HIF1 signaling. FASEB J. 22 (2008) 2662-2675
16. Fujita K., Ando M., Yamauchi M., Nagata Y., and Honda M. Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration. Neurochem. Res. 20 (1995) 1195-1201
17. Gill L.S., Pabbathi V.K., Vignes M., and Haynes L.W. Altered distribution of Galphah/type 2 transglutaminase following catecholamine deprivation is associated with depression of adrenoreceptor signal transduction in cultured ventricular zone germinal cells. Brain Res. 788 (1988) 95-103
18. Graesser D., Solowiej A., Bruckner M., Osterweil E., Juedes A., Davis S., Ruddle N.H., Engelhardt B., and Madri J.A. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109 (2002) 383-392
19. Green H. Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74 (1993) 955-956
20. Green J.B. Roads to neuralness: embryonic neural induction as derepression of a default state. Cell 77 (1994) 317-320
21. Greenberg C.S., Birckbichler P.J., and Rice R.J. Transglutaminase: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5 (1992) 3071-3077
22. Griffin M., Casadio R., and Bergamini C.M. Transglutaminase: nature's biological glues. Biochem. J. 368 (2002) 377-396
23. Hota S.K., Barhwal K., Singh S.B., Sairam M., and Ilavazhagan G. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia. J. Neurosci. Res. 86 (2008) 1142-1152
24. Hwang I.K., Kim D.W., Yoo K.Y., Jung B.K., Song J.H., Jung J.Y., Choi S.Y., Kang T.C., Lee J.Y., Kwon Y.G., and Won M.H. Ischemia-induced changes of platelet endothelial cell adhesion molecule-1 in the hippocampal CA1 region in gerbils. Brain Res. 1048 (2005) 251-257
25. Hwang I.K., Yoo K.Y., Kim D.W., Choi S.Y., Kang T.C., Kim Y.S., and Won M.H. Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia/reperfusion. Neurochem. Res. 31 (2006) 957-965
26. + exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 212 (2008) 314-323
27. Ientile R., Caccamo D., Marciano M.C., Currò M., Mannucci C., Campisi A., and Calapai G. Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia. Neurosci. Lett. 363 (2004) 173-177
28. Im M.J., Russell M.A., and Feng J.F. Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell. Signal. 9 (1997) 477-482
29. Johnson V.W.G., Cox M.T., Lockhart P.J., Zinnerman D.M., Miller L.M., and Powers E.R. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751 (1997) 323-329
30. Jung H.H., Lee J.J., Washington J.M., and Zuo Z. Inability of volatile anesthetics to inhibit oxygen-glucose deprivation-induced glutamate release via glutamate transporters and anion channels in rat corticostriatal slices. Brain Res. 1227 (2008) 234-239
31. Kim S.Y., Grant P., Lee J.H., Pant H.C., and Steinert P.M. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminase 1 and 2 in Alzheimer's disease. J. Biol. Chem. 274 (1999) 30715-30721
32. Kim D.H., Li H., Yoo K.Y., Lee B.H., Hwang I.K., and Won M.H. Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 204 (2007) 748-758
33. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239 (1982) 57-69
34. Kristián T., and Siesjö B.K. Calcium in ischemic cell death. Stroke 29 (1998) 705-718
35. Lai T.S., Hausladen A., Slaughter T.F., Eu J.P., Stamler J.S., and Greenberg C.S. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40 (2001) 4904-4910
36. Lesort M., Chun W., Johnson G.B.W., and Ferrante R.J. Tissue transglutaminase is increased in Huntington's disease brain. J. Neurochem. 73 (1999) 2018-2027
37. Lorand L. Neurodegenerative disease and transglutaminase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14310-14313
38. Loskota W.A., Lomax P., and Verity M.A. A Stereotaxic Atlas of the Mongolian Gerbil Brain (Meriones unguiculatus) (1974), Ann Arbor Science Publishers Inc., Ann Arbor 70-79
39. Maggio N., Sellitti S., Capano C.P., and Papa M. Tissue-transglutaminase in rat and human brain: light and electron immunocytochemical analysis and in situ hybridization study. Brain Res. Bull. 56 (2001) 173-182
40. Milakovic T., Tucholski J., McCoy E., and Johnson G.V. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J. Biol. Chem. 279 (2004) 8715-8722
41. Muller W.A., and Randolph G.J. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leukoc. Biol. 66 (1999) 698-704
42. Petito C.K., and Pulsinelli W.A. Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes. J. Cereb. Blood Flow Metab. 4 (1984) 194-205
43. Piredda L., Farrace M.G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., and Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 13 (1999) 355-364
44. Rothman S.M., and Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19 (1986) 105-111
45. Schenkel A.R., Chew T.W., and Muller W.A. Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J. Immunol. 173 (2004) 6403-6408
46. Tolentino P.J., Waghray A., Wang K.K., and Hayes R.L. Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats. J. Neurochem. 89 (2004) 1301-1307
47. Tremblay M.È., Saint-Pierre M., Bourhis E., Lévesque D., Rouillard C., and Cicchetti F. Neuroprotective effects of cystamine in aged Parkinsonian mice. Neurobiol. Aging 27 (2006) 862-870
48. Tucholski J., Lesort M., and Johnson G.V.W. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102 (2001) 481-491
49. Van Raamsdonk J.M., Pearson J., Bailey C.D.C., Rogers D.A., Johnson G.V.W., Hayden M.R., and Leavitt B.R. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J. Neurochem. 95 (2005) 210-220
50. Vig P.J., Wei J., Shao Q., Hebert M.D., Subramony S.H., and Sutton L.T. Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1. Neurosci. Lett. 420 (2007) 53-57
51. Walter I., Handler J., Miller I., and Aurich C. Matrix metalloproteinase 2 (MMP-2) and tissue transglutaminase (TG 2) are expressed in periglandular fibrosis in horse mares with endometrosis. Histol. Histopathol. 20 (2005) 1105-1113
52. Wang X., Sarkar A., Cicchetti F., Yu M., Zhu A., Jokivarsi K., Saint-Pierre M., and Brownell A.L. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. J. Neurol. Sci. 231 (2005) 57-66